Detailled Information

Name of the Instrument/Tool Combined Index of Severity of Fibromyalgia (ICAF)
First Description

Vallejo MA, Rivera J, Esteve-Vives J. Development of a self-reporting tool to obtain a combined index of severity of fibromyalgia (ICAF). Health and quality of life outcomes. 2010;8:2. Epub 2010/01/09.

Year 2010
Domains
Concept of constructs Anxiety and depression, Damage, Disease activity, Fatigue, Global assessment, Health related quality of life, Pain
Population/Disease Disease specific
Originally developed for Fibromyalgia (FM)
Other rheumatic diseases
where can be applied (only if validated)
---
Additional population with no rheumatic diseases No
Language: Originally published in English
Available in Language Spanish
REFERENCE IDENTIFICATION
Author/s Vallejo MA, Rivera J, Esteve-Vives J
Title Development of a self-reporting tool to obtain a combined index of severity of fibromyalgia (ICAF)
Journal Health Qual Life Outcomes
Year 2010
Vol 8
Num 2
Pages ---
Country Spain
Language English
Other references of interest
Link https://www.ncbi.nlm.nih.gov/pubmed/21649886
Brief Description

A confirmatory study of the Combined Index of Severity of Fibromyalgia (ICAF*): factorial structure, reliability and sensitivity to change.

Link https://www.ncbi.nlm.nih.gov/pubmed/24792366
Brief Description

The aim of this study was to establish the cutoff points in the Combined Index of Fibromyalgia Severity (ICAF) questionnaire which allow classification of patients by severity and to evaluate its application in the clinical practice.

Instrument/Tool Translations References
No other References.
DEVELOPER CONTACT INFORMATION
Correspondence to Miguel A Vallejo
E-Mail mvallejo@correo.cop.es
Address Facultad de Psicología, Universidad Nacional de Educación a Distancia. Madrid (Spain). C/ Juan del Rosal 10 28040 Madrid
Website ---
Available ---
Links ---
DESCRIPTION OF THE INSTRUMENT
Type Of Measure Questionnaire
Brief Description

The ICAF evaluates the main fibromyalgia symptoms in five domains: emotional (anxiety and depression), physical (pain, fatigue, sleep quality, and functional capacity), active coping (positive coping strategies), and passive coping.

Number of Items 59
Range 0-84
Responses options/scale No
Developed for Clinical practice
PRACTICAL APPLICATION
Method of administration Self-administered
Recommendations to score ---
Score Interpretation The higher the score, the worse. In the ICAF scoring sheet, besides the direct score, Z score and T score are expected to be calculated, based on Vallejo 2010
Cut-off points ---
Cut-off points applied to ---
Smallest detectable change if described ---
Smallest detectable change applied to ---
Completion time by the patient 0 minutes
Scoring time by the assessor 0 minutes
Training to score Not necessary
Strengths Useful in clinical practice & research
Limitations Complex scoring, Lengthy
OTHER COMMENTS
Other Comments

With the exception of the passive coping factor, all the other scores, including the overall score, were sensitive to change after the therapeutic intervention. The ICAF scores of the patients with fibromyalgia compared with those of the control group were markedly different. 

Conclusions: The findings suggest that the ICAF is a valid, reliable, sensitive to change instrument with the added advantage that it offers some additional domains (factors) that provide very valuable information regarding the most delicate aspects of the patient, which must be addressed at the time of treatment in daily clinical practice (Vallejo 2011)